메뉴 건너뛰기




Volumn 111, Issue 8, 2016, Pages 1141-1146

Recurrence of clostridium difficile infection in patients with inflammatory bowel disease: The RECIDIVISM study

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AMINOSALICYLIC ACID; AZATHIOPRINE; CYCLOSPORIN; INFLIXIMAB; MESALAZINE; METHOTREXATE; STEROID; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; GASTROINTESTINAL AGENT; GLUCOCORTICOID;

EID: 84970004349     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2016.187     Document Type: Article
Times cited : (101)

References (23)
  • 1
    • 0037204196 scopus 로고    scopus 로고
    • Clinical practice. Antibiotic-Associated diarrhea
    • Bartlett JG. Clinical practice. Antibiotic-Associated diarrhea. N Engl J Med 2002; 346: 334-9.
    • (2002) N Engl J Med , vol.346 , pp. 334-339
    • Bartlett, J.G.1
  • 2
    • 33644523410 scopus 로고    scopus 로고
    • C lostridium diffi cile infection in patients discharged from US short-stay hospitals 1996-2003
    • McDonald LC, Owings M, Jernigan DB. C lostridium diffi cile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis 2006; 12: 409-15.
    • (2006) Emerg Infect Dis , vol.12 , pp. 409-415
    • McDonald, L.C.1    Owings, M.2    Jernigan, D.B.3
  • 3
    • 34447542645 scopus 로고    scopus 로고
    • Increasing prevalence and severity of Clostridium diffi cile colitis in hospitalized patients in the United States
    • Ricciardi R, Rothenberger DA, Madoff RD, et al. Increasing prevalence and severity of Clostridium diffi cile colitis in hospitalized patients in the United States. Arch Surg 2007; 142: 624-31.
    • (2007) Arch Surg , vol.142 , pp. 624-631
    • Ricciardi, R.1    Rothenberger, D.A.2    Madoff, R.D.3
  • 4
    • 84901373449 scopus 로고    scopus 로고
    • Managing Clostridium diffi cile in Inflammatory bowel disease (IBD)
    • Hashash JG, Binion DG. Managing Clostridium diffi cile in Inflammatory bowel disease (IBD). Curr Gastroenterol Rep 2014; 16: 393.
    • (2014) Curr Gastroenterol Rep , vol.16 , pp. 393
    • Hashash, J.G.1    Binion, D.G.2
  • 5
    • 44949261865 scopus 로고    scopus 로고
    • A national survey of the prevalence and impact of Clostridium diffi cile infection among hospitalized Inflammatory bowel disease patients
    • Nguyen GC, Kaplan GG, Harris ML, et al. A national survey of the prevalence and impact of Clostridium diffi cile infection among hospitalized Inflammatory bowel disease patients. Am J Gastroenterol 2008; 103: 1443-50.
    • (2008) Am J Gastroenterol , vol.103 , pp. 1443-1450
    • Nguyen, G.C.1    Kaplan, G.G.2    Harris, M.L.3
  • 6
    • 84925771391 scopus 로고    scopus 로고
    • Risk factors and management of refractory or recurrent Clostridium diffi cile infection in ileal pouch patients
    • Seril DN, Ashburn JH, Lian L, et al. Risk factors and management of refractory or recurrent Clostridium diffi cile infection in ileal pouch patients. Inflamm Bowel Dis 2014; 20: 2226-33.
    • (2014) Inflamm Bowel Dis , vol.20 , pp. 2226-2233
    • Seril, D.N.1    Ashburn, J.H.2    Lian, L.3
  • 7
    • 56249107224 scopus 로고    scopus 로고
    • Meta-Analysis to assess risk factors for recurrent Clostridium diffi cile infection
    • Garey KW, Sethi S, Yadav Y, et al. Meta-Analysis to assess risk factors for recurrent Clostridium diffi cile infection. J Hosp Infect 2008; 70: 298-304
    • (2008) J Hosp Infect , vol.70 , pp. 298-304
    • Garey, K.W.1    Sethi, S.2    Yadav, Y.3
  • 8
    • 67349239352 scopus 로고    scopus 로고
    • Recurrent Clostridium diffi cile infection: A review of risk factors, treatments, and outcomes
    • Johnson S. Recurrent Clostridium diffi cile infection: a review of risk factors, treatments, and outcomes. J Infect 2009; 58: 403-10.
    • (2009) J Infect , vol.58 , pp. 403-410
    • Johnson, S.1
  • 9
    • 84921767408 scopus 로고    scopus 로고
    • Diagnosis and treatment of Clostridium diffi cile in adults: A systematic review
    • Bagdasarian N, Rao K, Malani PN. Diagnosis and treatment of Clostridium diffi cile in adults: a systematic review. JAMA 2015; 313: 398-408.
    • (2015) JAMA , vol.313 , pp. 398-408
    • Bagdasarian, N.1    Rao, K.2    Malani, P.N.3
  • 10
    • 84978221604 scopus 로고    scopus 로고
    • Lumnial toxin-binding agents for Clostridium diffi cile infection
    • e-pub ahead of print)
    • McCoy RM, Klick A, Hill S, et al. Lumnial toxin-binding agents for Clostridium diffi cile infection. J Pharm Pract 2016 (e-pub ahead of print).
    • (2016) J Pharm Pract
    • McCoy, R.M.1    Klick, A.2    Hill, S.3
  • 11
    • 79151476267 scopus 로고    scopus 로고
    • Intravenous immunoglobulin for the treatment of Clostridium diffi cile infection: A review
    • Abougergi MS, Kwon JH. Intravenous immunoglobulin for the treatment of Clostridium diffi cile infection: a review. Dig Dis Sci 2011; 56: 19-26.
    • (2011) Dig Dis Sci , vol.56 , pp. 19-26
    • Abougergi, M.S.1    Kwon, J.H.2
  • 12
    • 84919774569 scopus 로고    scopus 로고
    • Probiotics for antibiotic-Associated diarrhea do we have a verdict?
    • Issa I, Moucari R. Probiotics for antibiotic-Associated diarrhea: do we have a verdict? World J Gastroenterol 2014; 20: 17788-95.
    • (2014) World J Gastroenterol , vol.20 , pp. 17788-17795
    • Issa, I.1    Moucari, R.2
  • 13
    • 79551527297 scopus 로고    scopus 로고
    • Fidaxomicin versus vancomycin for Clostridium diffi cile infection
    • Louie TJ, Miller MA, Mullane KM, et al. Fidaxomicin versus vancomycin for Clostridium diffi cile infection. N Engl J Med 2011; 364: 422-31.
    • (2011) N Engl J Med , vol.364 , pp. 422-431
    • Louie, T.J.1    Miller, M.A.2    Mullane, K.M.3
  • 14
    • 84884553359 scopus 로고    scopus 로고
    • Is C lostridium diffi cile associated with relapse of Inflammatory bowel disease? Results from a retrospective and prospective cohort study in the Netherlands
    • Masclee GM, Penders J, Jonkers DM, et al. Is C lostridium diffi cile associated with relapse of Inflammatory bowel disease? Results from a retrospective and prospective cohort study in the Netherlands. Inflamm Bowel Dis 2013; 19: 2125-31.
    • (2013) Inflamm Bowel Dis , vol.19 , pp. 2125-2131
    • Masclee, G.M.1    Penders, J.2    Jonkers, D.M.3
  • 15
    • 84923034822 scopus 로고    scopus 로고
    • Recurrent C lostridium diffi cile infection is associated with increased mortality
    • Olsen MA, Yan Y, Reske KA, et al. Recurrent C lostridium diffi cile infection is associated with increased mortality. Clin Microbiol Infect 2014; 21: 164-70.
    • (2014) Clin Microbiol Infect , vol.21 , pp. 164-170
    • Olsen, M.A.1    Yan, Y.2    Reske, K.A.3
  • 16
    • 84929250733 scopus 로고    scopus 로고
    • Risk factors for recurrent Clostridium diffi cile infection: A systematic review and meta-Analysis
    • Deshpande A, Pasupleti V, Thota P, et al. Risk factors for recurrent Clostridium diffi cile infection: a systematic review and meta-Analysis. Infect Control Hosp Epidemiol 2015; 00: 1-9.
    • (2015) Infect Control Hosp Epidemiol , pp. 1-9
    • Deshpande, A.1    Pasupleti, V.2    Thota, P.3
  • 17
    • 62949146399 scopus 로고    scopus 로고
    • Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium diffi cile infection
    • Hu MY, Katchar K, Kyne L, et al. Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium diffi cile infection. Gastroenterology 2009; 136: 1206-14.
    • (2009) Gastroenterology , vol.136 , pp. 1206-1214
    • Hu, M.Y.1    Katchar, K.2    Kyne, L.3
  • 18
    • 0035915688 scopus 로고    scopus 로고
    • Association between antibody response to toxin A and protection against recurrent Clostridium diffi cile diarrhea
    • Kyne L, Warny M, Qamar A, et al. Association between antibody response to toxin A and protection against recurrent Clostridium diffi cile diarrhea. Lancet 2001; 357: 189-93.
    • (2001) Lancet , vol.357 , pp. 189-193
    • Kyne, L.1    Warny, M.2    Qamar, A.3
  • 19
    • 0028089161 scopus 로고
    • Human antibody response to Clostridium diffi cile toxin A in relation to clinical course of infection
    • Warny M, Vaerman JP, Avesani V, et al. Human antibody response to Clostridium diffi cile toxin A in relation to clinical course of infection. Infect Immun 1994; 62: 384-9.
    • (1994) Infect Immun , vol.62 , pp. 384-389
    • Warny, M.1    Vaerman, J.P.2    Avesani, V.3
  • 20
    • 84899796356 scopus 로고    scopus 로고
    • Risk estimation for recurrent Clostridium diffi cile infection based on clinical factors
    • D?Agostino RB, Collins SH, Pencina KM, et al. Risk estimation for recurrent Clostridium diffi cile infection based on clinical factors. Clin Infect Dis 2014; 58: 1386-93.
    • (2014) Clin Infect Dis , vol.58 , pp. 1386-1393
    • D'Agostino, R.B.1    Collins, S.H.2    Pencina, K.M.3
  • 21
    • 36549001139 scopus 로고    scopus 로고
    • The prevalence and geographic distribution of Crohn?s disease and ulcerative colitis in the United States
    • Kappelman MD, Rifas-Shiman SL, Kleinman K, et al. The prevalence and geographic distribution of Crohn?s disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol 2007; 5: 1424-9.
    • (2007) Clin Gastroenterol Hepatol , vol.5 , pp. 1424-1429
    • Kappelman, M.D.1    Rifas-Shiman, S.L.2    Kleinman, K.3
  • 22
    • 84876384416 scopus 로고    scopus 로고
    • Risk factors and outcome of PCR-detected Clostridium diffi cile infection in ileal pouch patients
    • Li Y, Qian J, Queener E, et al. Risk factors and outcome of PCR-detected Clostridium diffi cile infection in ileal pouch patients. Inflamm Bowel Dis 2013; 19: 397-403.
    • (2013) Inflamm Bowel Dis , vol.19 , pp. 397-403
    • Li, Y.1    Qian, J.2    Queener, E.3
  • 23
    • 84923922666 scopus 로고    scopus 로고
    • The impact of proton pump inhibitors on the human gastrointestinal microbiome
    • Freedberg DE, Lebwohl B, Abrams JA. The impact of proton pump inhibitors on the human gastrointestinal microbiome. Clin Lab Med 2014; 34: 771-85.
    • (2014) Clin Lab Med , vol.34 , pp. 771-785
    • Freedberg, D.E.1    Lebwohl, B.2    Abrams, J.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.